Windamere Venture Partners

Total investments

11

Average round size

27M

Portfolio companies

10

Rounds per year

0.46

Follow on index

0.09

Exits

6

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareManufacturingMedical DeviceMedicalPharmaceuticalBiopharmaDiabetes

Summary

Windamere Venture Partners appeared to be the VC, which was created in 1998. The venture was found in North America in United States. The main office of represented VC is situated in the La Jolla.

The top amount of exits for fund were in 2005. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Windamere Venture Partners performs on 31 percentage points more the average number of lead investments. The high activity for fund was in 2004.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Santarus, Cianna Medical, Avera Pharmaceutical. Among the most successful fund investment fields, there are Pharmaceutical, Health Care. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Windamere Venture Partners, startups are often financed by St. Paul Venture Capital, InterWest Partners, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Fog City Capital, St. Paul Venture Capital, Domain Associates. In the next rounds fund is usually obtained by Domain Associates, St. Paul Venture Capital, Montreux Equity Partners.

The overall number of key employees were 2.

Show more

Investments analytics

Analytics

Total investments
11
Lead investments
0
Exits
6
Rounds per year
0.46
Follow on index
0.09
Investments by industry
  • Biotechnology (7)
  • Health Care (6)
  • Pharmaceutical (4)
  • Medical (4)
  • Medical Device (3)
  • Show 3 more
Investments by region
  • United States (9)
Peak activity year
2005
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
305M
Group Appearance index
1.00
Avg. company exit year
9
Avg. multiplicator
2.64

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Santarus 08 Mar 2001 Biotechnology, Health Care, Biopharma Late Stage Venture 33M United States, California, San Diego

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.